XML 54 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-based Compensation Plans (Narrative) (Details)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Jan. 27, 2021
Dec. 02, 2020
Jun. 30, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
shares
Share-based Payment Arrangement, Expense | $     $ 3.4     $ 1.8 $ 8.4 $ 5.0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $     $ 11.5       $ 11.5  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     131,178     474,423 566,666 274,009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares     0       108,950  
Phantom Share Units (PSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value | $ / shares     $ 14.42       $ 14.42  
Share-based compensation liability | $     $ 2.7       $ 2.7  
Granted, shares     3,567 1,254 180,987      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares     $ 14.29 $ 11.94 $ 11.86      
Granted, shares     3,567 1,254 180,987      
Performance Shares [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period             103,058  
Share-based compensation, units awarded but not yet granted     199,994       199,994  
Restricted Stock Units (RSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     2,324       221,873  
Granted, shares     7,127 82,565 129,081      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares     $ 13.32 $ 12.81 $ 11.86      
Granted, shares     7,127 82,565 129,081      
Market Based Performance Shares                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 1.84% 1.77%            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0.16% 0.21%            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 8 months 1 day 2 years 9 months 29 days            
Granted, shares       4,187 234,199      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 1.84% 1.77%            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares       $ 14.26 $ 15.39      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0.16% 0.21%            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 8 months 1 day 2 years 9 months 29 days            
Granted, shares       4,187 234,199      
Equity Option                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     2.01% 2.01%        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.66% 0.66%        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     6 years 6 years        
Granted, shares       8,115 423,405      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     2.01% 2.01%        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares       $ 3.08 $ 3.05      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.66% 0.66%        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     6 years 6 years        
Granted, shares       8,115 423,405      
Minimum [Member] | Performance Shares [Member]                
Performance Factors             0  
Minimum [Member] | Market Based Performance Shares                
Performance Factors             0  
Maximum [Member] | Performance Shares [Member]                
Performance Factors             2  
Maximum [Member] | Market Based Performance Shares                
Performance Factors             2  
Share-based Payment Arrangement, Tranche Two [Member] | Performance Shares [Member]                
Granted, shares         60,019      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares         $ 11.86      
Granted, shares         60,019      
Share-based Payment Arrangement, Tranche Three [Member] | Performance Shares [Member]                
Granted, shares         84,483      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares         $ 11.86      
Granted, shares         84,483